1 Introduction to Research & Analysis Reports 1.1 Systemic Lupus Erythematosus (SLE) Drugs Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Systemic Lupus Erythematosus (SLE) Drugs Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Systemic Lupus Erythematosus (SLE) Drugs Overall Market Size 2.1 China Systemic Lupus Erythematosus (SLE) Drugs Market Size: 2021 VS 2027 2.2 China Systemic Lupus Erythematosus (SLE) Drugs Revenue, Prospects & Forecasts: 2016-2027 2.3 China Systemic Lupus Erythematosus (SLE) Drugs Sales: 2016-2027 3 Company Landscape 3.1 Top Systemic Lupus Erythematosus (SLE) Drugs Players in China Market 3.2 Top China Systemic Lupus Erythematosus (SLE) Drugs Companies Ranked by Revenue 3.3 China Systemic Lupus Erythematosus (SLE) Drugs Revenue by Companies 3.4 China Systemic Lupus Erythematosus (SLE) Drugs Sales by Companies 3.5 China Systemic Lupus Erythematosus (SLE) Drugs Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Systemic Lupus Erythematosus (SLE) Drugs Companies in China Market, by Revenue in 2020 3.7 Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Product Type 3.8 Tier 1, Tier 2 and Tier 3 Systemic Lupus Erythematosus (SLE) Drugs Players in China Market 3.8.1 List of Tier 1 Systemic Lupus Erythematosus (SLE) Drugs Companies in China 3.8.2 List of Tier 2 and Tier 3 Systemic Lupus Erythematosus (SLE) Drugs Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Market Size Markets, 2021 & 2027 4.1.2 Corticosteroids 4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 4.1.4 Anti-Inflammatories 4.1.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs) 4.1.6 Antimalarials 4.1.7 BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS) 4.1.8 Immunosuppressive Agents/Immune Modulators 4.1.9 Anticoagulants 4.2 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue & Forecasts 4.2.1 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2021 4.2.2 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2022-2027 4.2.3 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027 4.3 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales & Forecasts 4.3.1 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2021 4.3.2 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales, 2022-2027 4.3.3 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027 4.4 By Type - China Systemic Lupus Erythematosus (SLE) Drugs Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Market Size, 2021 & 2027 5.1.2 Intravenous 5.1.3 Sub-Cutaneous 5.1.4 Oral 5.1.5 Topical 5.2 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue & Forecasts 5.2.1 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2021 5.2.2 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2022-2027 5.2.3 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027 5.3 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales & Forecasts 5.3.1 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales, 2016-2021 5.3.2 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales, 2022-2027 5.3.3 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027 5.4 By Application - China Systemic Lupus Erythematosus (SLE) Drugs Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Anthera Pharmaceuticals 6.1.1 Anthera Pharmaceuticals Corporation Information 6.1.2 Anthera Pharmaceuticals Overview 6.1.3 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in China Market (2016-2021) 6.1.4 Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Product Description 6.1.5 Anthera Pharmaceuticals Recent Developments 6.2 GSK 6.2.1 GSK Corporation Information 6.2.2 GSK Overview 6.2.3 GSK Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in China Market (2016-2021) 6.2.4 GSK Systemic Lupus Erythematosus (SLE) Drugs Product Description 6.2.5 GSK Recent Developments 6.3 ImmuPharma 6.3.1 ImmuPharma Corporation Information 6.3.2 ImmuPharma Overview 6.3.3 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in China Market (2016-2021) 6.3.4 ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Product Description 6.3.5 ImmuPharma Recent Developments 6.4 Johnson & Johnson 6.4.1 Johnson & Johnson Corporation Information 6.4.2 Johnson & Johnson Overview 6.4.3 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Sales and Revenue in China Market (2016-2021) 6.4.4 Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Product Description 6.4.5 Johnson & Johnson Recent Developments 7 China Systemic Lupus Erythematosus (SLE) Drugs Production Capacity, Analysis 7.1 China Systemic Lupus Erythematosus (SLE) Drugs Production Capacity, 2016-2027 7.2 Systemic Lupus Erythematosus (SLE) Drugs Production Capacity of Key Manufacturers in China Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Systemic Lupus Erythematosus (SLE) Drugs Supply Chain Analysis 9.1 Systemic Lupus Erythematosus (SLE) Drugs Industry Value Chain 9.2 Systemic Lupus Erythematosus (SLE) Drugs Upstream Market 9.3 Systemic Lupus Erythematosus (SLE) Drugs Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Systemic Lupus Erythematosus (SLE) Drugs Distributors and Sales Agents in China Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Systemic Lupus Erythematosus (SLE) Drugs in China Market Table 2. Top Systemic Lupus Erythematosus (SLE) Drugs Players in China Market, Ranking by Revenue (2019) Table 3. China Systemic Lupus Erythematosus (SLE) Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 4. China Systemic Lupus Erythematosus (SLE) Drugs Revenue Share by Companies, 2016-2021 Table 5. China Systemic Lupus Erythematosus (SLE) Drugs Sales by Companies, (K MT), 2016-2021 Table 6. China Systemic Lupus Erythematosus (SLE) Drugs Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Price (2016-2021) & (USD/MT) Table 8. Manufacturers Systemic Lupus Erythematosus (SLE) Drugs Product Type Table 9. List of Tier 1 Systemic Lupus Erythematosus (SLE) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Systemic Lupus Erythematosus (SLE) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Corticosteroids Table 12. Major Manufacturers of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Table 13. By Type – China Systemic Lupus Erythematosus (SLE) Drugs Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue (US$, Mn), 2016-2021 Table 15. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue (US$, Mn), 2022-2027 Table 16. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), 2016-2021 Table 17. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), 2022-2027 Table 18. By Application – China Systemic Lupus Erythematosus (SLE) Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue (US$, Mn), 2016-2021 Table 20. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue (US$, Mn), 2022-2027 Table 21. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), 2016-2021 Table 22. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), 2022-2027 Table 23. Anthera Pharmaceuticals Corporation Information Table 24. Anthera Pharmaceuticals Description and Major Businesses Table 25. Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 26. Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Product Table 27. Anthera Pharmaceuticals Recent Developments Table 28. GSK Corporation Information Table 29. GSK Description and Major Businesses Table 30. GSK Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 31. GSK Systemic Lupus Erythematosus (SLE) Drugs Product Table 32. GSK Recent Developments Table 33. ImmuPharma Corporation Information Table 34. ImmuPharma Description and Major Businesses Table 35. ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 36. ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Product Table 37. ImmuPharma Recent Developments Table 38. Johnson & Johnson Corporation Information Table 39. Johnson & Johnson Description and Major Businesses Table 40. Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 41. Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Product Table 42. Johnson & Johnson Recent Developments Table 43. Systemic Lupus Erythematosus (SLE) Drugs Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT) Table 44. China Systemic Lupus Erythematosus (SLE) Drugs Capacity Market Share of Key Manufacturers, 2019-2021 Table 45. Systemic Lupus Erythematosus (SLE) Drugs Market Opportunities & Trends in China Market Table 46. Systemic Lupus Erythematosus (SLE) Drugs Market Drivers in China Market Table 47. Systemic Lupus Erythematosus (SLE) Drugs Market Restraints in China Market Table 48. Systemic Lupus Erythematosus (SLE) Drugs Raw Materials Table 49. Systemic Lupus Erythematosus (SLE) Drugs Raw Materials Suppliers in China Market Table 50. Typical Systemic Lupus Erythematosus (SLE) Drugs Downstream Table 51. Systemic Lupus Erythematosus (SLE) Drugs Downstream Clients in China Market Table 52. Systemic Lupus Erythematosus (SLE) Drugs Distributors and Sales Agents in China Market List of Figures Figure 1. Systemic Lupus Erythematosus (SLE) Drugs Product Picture Figure 2. Systemic Lupus Erythematosus (SLE) Drugs Segment by Type Figure 3. Systemic Lupus Erythematosus (SLE) Drugs Segment by Application Figure 4. China Systemic Lupus Erythematosus (SLE) Drugs Market Overview: 2020 Figure 5. China Systemic Lupus Erythematosus (SLE) Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 6. China Systemic Lupus Erythematosus (SLE) Drugs Revenue, 2016-2027 (US$, Mn) Figure 7. Systemic Lupus Erythematosus (SLE) Drugs Sales in China Market: 2016-2027 (K MT) Figure 8. The Top 3 and 5 Players Market Share by Systemic Lupus Erythematosus (SLE) Drugs Revenue in 2020 Figure 9. Corticosteroids Product Picture Figure 10. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture Figure 11. Anti-Inflammatories Product Picture Figure 12. Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Product Picture Figure 13. Antimalarials Product Picture Figure 14. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027 Figure 15. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027 Figure 16. By Type - China Systemic Lupus Erythematosus (SLE) Drugs Price (USD/MT), 2016-2027 Figure 17. Intravenous Figure 18. Sub-Cutaneous Figure 19. Oral Figure 20. Topical Figure 21. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Sales Market Share, 2016-2027 Figure 22. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Revenue Market Share, 2016-2027 Figure 23. By Application - China Systemic Lupus Erythematosus (SLE) Drugs Price (USD/MT), 2016-2027 Figure 24. Anthera Pharmaceuticals Systemic Lupus Erythematosus (SLE) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. GSK Systemic Lupus Erythematosus (SLE) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. ImmuPharma Systemic Lupus Erythematosus (SLE) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Johnson & Johnson Systemic Lupus Erythematosus (SLE) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. China Systemic Lupus Erythematosus (SLE) Drugs Production Capacity (K MT), 2016-2027 Figure 29. Systemic Lupus Erythematosus (SLE) Drugs Industry Value Chain Figure 30. Marketing Channels

Anthera Pharmaceuticals GSK ImmuPharma Johnson & Johnson